Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares pursuant to ESOP-2017 Scheme14-04-2022
14-04-2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
Net Sales are expected to increase by 12.2 percent Y-o-Y (down 6.1 percent Q-o-Q) to Rs 312.1 crore, according to Prabhudas Lilladher.14-04-2022
Eris Lifesciences Ltd - 540596 - Shareholding for the Period Ended January 01, 2020
Eris Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended January 01, 2020. For more details, kindly Click here04-04-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING04-04-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 25TH MARCH, 2022.25-03-2022
Eris Lifesciences Ltd - 540596 - Closure of Trading Window
INTIMATION OF CLOSURE OF TRADING WINDOW24-03-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 9TH MARCH, 202209-03-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 1ST MARCH, 2022.01-03-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 25TH FEBRUARY, 202225-02-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 23RD FEBRUARY, 202223-02-2022